Acta Oncologica
Volume 62, 2023 - Issue 4
Open access
2,925
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
Andreas Josefssona Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;b Wallenberg Center for Molecular Medicin, Umeå University, Umeå, Sweden;c Department of Urology and Andrology, Institute of surgery and perioperative Sciences, Umeå University, Umeå, SwedenView further author information
, Åsa Jellvertd Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;e Region Västra Götaland, NU Hospital Group, Department of Surgery, Uddevalla, Sweden;f Department of Oncology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenView further author information
, Erik Holmbergd Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden;g Regional Cancer Centre West, Gothenburg, Sweden
https://orcid.org/0000-0001-5107-4550View further author information
Klaus Brassoh Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkView further author information
, Peter Meidahl Peterseni Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, DenmarkView further author information
, Sirpa Aaltomaaj Department of Urology, Kuopio University Hospital, Kuopio, FinlandView further author information
, Marjaana Luukkaak Department of Oncology, Turku University Hospital, Turku, FinlandView further author information
, Paul Verhagenl Department of Urology, Erasmus Medical Centre, Rotterdam, the NetherlandsView further author information
, Ronald de Witm Department of Medical Oncology, Erasmus University Medical Centre Cancer Institute, Rotterdam, the NetherlandsView further author information
, Göran Ahlgrenn Department of Urology, Lund University, Skåne University Hospital, SwedenView further author information
, Ove Andréno School of Medical Sciences, Örebro University, Örebro, SwedenView further author information
, Enrique Castellanosp Department of Oncology, Karolinska University Hospital, Stockholm, SwedenView further author information
, Mihalj Sekeq Centrallasarettet Växjö, Växjö, SwedenView further author information
, Anders Widmarkr Department of Radiation Sciences, Umeå University, Umeå, Sweden
https://orcid.org/0000-0001-9845-055XView further author information
Jan-Erik Dambera Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenCorrespondence[email protected]
View further author information
& the SPCG14-investigators show allView further author information
Pages 372-380
|
Received 16 Nov 2022, Accepted 16 Mar 2023, Published online: 19 Apr 2023
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.